Feeds:
Posts
Comments

Posts Tagged ‘asymptomatic hormone refractory metastatic prostate cancer.’

JULY 30: PR NEWSWIRE.COM: Oncologists expect to prescribe the new vaccine for advanced prostate cancer,  Provenge, to 54 percent of patients with asymptomatic hormone refractory metastatic prostate cancer. READ MORE>

Read Full Post »